Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(0)
# 4789
Out of 5,298 analysts
315
Total ratings
24.47%
Success rate
-27.02%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Reiterates: Neutral | 75 75 | 57.93 | 29.47% | 9 | Apr 4, 2025 | |
KYTX Kyverna Therapeutics | Maintains: Neutral | 6 4 | 1.98 | 102.02% | 6 | Apr 3, 2025 | |
MGX Metagenomi | Maintains: Buy | 14 7 | 1.35 | 418.52% | 9 | Apr 3, 2025 | |
ZURA Zura Bio | Maintains: Neutral | 5 3 | 1.04 | 188.46% | 6 | Apr 3, 2025 | |
IPSC Century Therapeutics | Maintains: Buy | 5 2 | 0.44 | 354.55% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 9 | 1.26 | 614.29% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 8.09 | 270.83% | 19 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 23 | 2.46 | 834.96% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 9.74 | 54% | 10 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 50 | 8.96 | 458.04% | 14 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 3.67 | 308.72% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 4.64 | 223.28% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 115 115 | 14.23 | 708.15% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.5 | 900% | 19 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 45 40 | 10.75 | 272.09% | 16 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1 1 | 0.49 | 104.08% | 11 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 73 75 | 31.73 | 136.37% | 35 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 34 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 16.32 | 574.02% | 14 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 6.86 | 337.32% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 44 44 | 17.66 | 149.15% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 65 65 | 32.62 | 99.26% | 2 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | n/a | n/a | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 112 48 | n/a | n/a | 3 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 40000 610000 | n/a | n/a | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 36 | n/a | n/a | 4 | Nov 22, 2022 |